An integrative approach for a network based meta-analysis of viral RNAi screens. by Amberkar, S.S. & Kaderali, L.
Amberkar and Kaderali Algorithms for Molecular Biology  (2015) 10:6 
DOI 10.1186/s13015-015-0035-7
RESEARCH Open Access
An integrative approach for a network based
meta-analysis of viral RNAi screens
Sandeep S Amberkar1,2,3 and Lars Kaderali1,2*
Abstract
Background: Big data is becoming ubiquitous in biology, and poses significant challenges in data analysis and
interpretation. RNAi screening has become a workhorse of functional genomics, and has been applied, for example, to
identify host factors involved in infection for a panel of different viruses. However, the analysis of data resulting from
such screens is difficult, with often low overlap between hit lists, even when comparing screens targeting the same
virus. This makes it a major challenge to select interesting candidates for further detailed, mechanistic experimental
characterization.
Results: To address this problem we propose an integrative bioinformatics pipeline that allows for a network based
meta-analysis of viral high-throughput RNAi screens. Initially, we collate a human protein interaction network from
various public repositories, which is then subjected to unsupervised clustering to determine functional modules.
Modules that are significantly enriched with host dependency factors (HDFs) and/or host restriction factors (HRFs) are
then filtered based on network topology and semantic similarity measures. Modules passing all these criteria are
finally interpreted for their biological significance using enrichment analysis, and interesting candidate genes can be
selected from the modules.
Conclusions: We apply our approach to seven screens targeting three different viruses, and compare results with
other published meta-analyses of viral RNAi screens. We recover key hit genes, and identify additional candidates from
the screens. While we demonstrate the application of the approach using viral RNAi data, the method is generally
applicable to identify underlying mechanisms from hit lists derived from high-throughput experimental data, and to
select a small number of most promising genes for further mechanistic studies.
Keywords: Network analysis, RNAi screening, Virus-host interactions
Background
RNA interference (RNAi) has become an important
workhorse of functional genomics, and genome-wide
RNAi screens have been employed for example to identify
genes involved in cell growth and viability, proliferation,
differentiation, signaling or trafficking [1-9]. The technol-
ogy has furthermore accelerated the discovery of novel
host dependency factors (HDF) and host restriction fac-
tors (HRF) in viral infection [10-19]. However, while RNAi
is a very powerful tool to identify genes involved in a
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specific biological process, the placement of hits in their
functional and spatiotemporal context in the underlying
molecular processes remains a major challenge [20,21].
The interpretation of RNAi data in particular for virus
screens is complicated further by the observed low overlap
between identified host factors, even in different screens
targeting the same virus [22-24]. This low overlap has
been explained by different experimental conditions such
as host cell type and viral strain used, transfection, incu-
bation and infection time, and siRNA library used [24]
as well as by technical artifacts arising from cell popula-
tion context [25,26]. Furthermore, due to the typical setup
of RNAi experiments with primary screens followed by
secondary validation assays, it is likely that published hit
lists are highly specific, but not very sensitive, further
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explaining the low overlap observed between different
screens at the level of individual genes [27]. This, however,
severely restricts a comparative analysis of inter-species
RNAi screens [28]. On the other hand, protein interac-
tion networks, virus-host interaction networks and other
heterogeneous data have increased tremendously [29-34].
This offers novel ways to interpret hit lists from RNAi
experiments from a network perspective, by integrating
individual hits in their systemic context. It has been shown
that this approach increases the overlap between differ-
ent screens for the same virus at the pathway level [24],
and the method can be extended to meta-analysis of
screens targeting different viruses. Being less dependent
on individual genes, but rather focusing on pathways, may
shed new light onto virus-specific and generic host pro-
cesses facilitating or restricting infection, and may prove
a promising approach to identify potential host targets for
antiviral drug development.
Several meta-analyses of RNAi screens have been con-
ducted, albeit most work focused on integrating different
screens targeting a single virus [24,28,35,36]. A notable
exception is the study by Snijder et al., including 45
screens targeting 17 different mammalian viruses [37].
The authors show that accounting for cellular hetero-
geneity improves gene overlaps between screens, but the
study does not focus on functional regions within the
host protein network targeted by different viruses. In
contrast, Navratil et al. study virus-host protein inter-
actions in the human interferon network [32], throw-
ing light on how viruses of different families target the
innate immune system. Other similar analyses focused
largely on HIV, for example, Murali et al. employed
a semi-supervised machine learning approach mapping
RNAi hits onto a protein interaction network to predict
new HDFs [38]. Macpherson et al. and similarly Maulik
et al. mine the HIV-1 human protein interaction net-
work using biclustering, and identify biclusters enriched
with GO terms and RNAi hits [39,40]. Several authors
have furthermore used protein-protein interaction (PPI)
networks to identify topological properties of proteins
targeted by pathogens. Dyer et al. characterized host
proteins targeted by 190 different pathogens, includ-
ing 35 viruses, 17 bacterial and two protozoan groups
[29]. One of the major outcomes of this analysis was
that pathogens preferentially target proteins with high
node betweenness (bottlenecks) or high degree (hubs).
Similarly, the studies by Dijk et al. and Dickerson
et al. both showed that HIV preferentially targets hub
and bottleneck genes in the human protein network
[30,31]. Further characterizing the neighborhood of
HDFs, Gulbahce et al. showed that proteins translated
from genes involved in viral diseases are most likely
located in the neighborhood of their corresponding viral
targets [33].
Given the typically low overlap between different RNAi
screens at the gene level and the relatively long hit
lists resulting from individual screens, a central problem
is how to select most promising candidates for func-
tional characterization and detailed biochemical follow-
up experiments. When looking for putative antiviral drug
targets, one is typically interested in candidates that have
a significant impact on infection outcome in the specific
virus under consideration, or possibly even in several dif-
ferent viral species if e.g. broadly acting antivirals are
sought for. Corresponding target pathways should there-
fore be “enriched” by hit genes from the RNAi data, while
at the same time it is desirable that the respective tar-
gets are centrally located in the virus-host interaction
network.
In this manuscript, we present a comparative analy-
sis of RNAi hits for different viruses in the context of
functional modules of protein interaction networks. The
main purpose of our work is in hit prioritization, that
is, we strive to identify a small set of candidates for
further detailed follow-up experiments. We cluster the
host protein network to identify functional host mod-
ules, and then use a statistical test to identify modules
enriched with hits from seven genome-wide RNAi screens
for three different viruses. Network topological charac-
teristics are used to filter relevant subnetworks further,
and resulting modules and their neighborhoods are anno-
tated and interpreted. Using this approach, we identified
several interesting candidate pathways for human immun-
odeficiency virus 1 (HIV-1) and hepatitis C virus (HCV),
including known targets such as the mediator complex or
members of the heterogeneous nuclear ribonucleoprotein
subunits (hnRNPs) in HIV infection, or MAP kinases and
heat shock proteins in HCV infection. Furthermore, using
our approach, we predict that SERCA1 and Tankyrase-1
(TNKS1) may be interesting targets for further character-
ization in HCV infection.
Materials andmethods
An overview of the data analysis pipeline used is shown in
Figure 1. In brief, we collate information from 11 different
public protein-protein interaction (PPI) data repositories,
and integrate them into a large human PPI network. Sub-
sequently, we use a cohesiveness-based greedy clustering
algorithm to identify –possibly overlapping– clusters in
the protein network, which are then tested for enrich-
ment of hits from one or several RNAi screens. Significant
modules are then filtered further using topological prop-
erties and semantic similarity, and functionally character-
ized using gene ontology and Reactome pathways. Using
tissue-specific expression data, we predict novel putative
host factors based on neighborhood relations in identified
modules. We describe each of these steps in more detail
in the following.
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Figure 1 Overview of the data analysis pipeline. (1) Protein interactions from public databases are collated to build an integrated human PPI
network. (2) Greedy unsupervised clustering is used to identify relevant, possibly overlapping, submodules in the PPI network. (3) Hits from one or
several RNAi screens are mapped to these modules and modules are filtered for significant enrichment. (4) Subnetworks are further filtered based
on network topology and semantic similarity values. (5) Resulting modules are visualized as subnetworks, color-coded for hits, non-hits, and (6a,b)
are then functionally characterized based on GO and Reactome pathway. (6c) Lastly, using gene expression data from different tissues, tissue-specific
putative novel host factors are predicted.
Human protein interaction network:
The human protein interaction network was collated from
two major resources: the iRefIndex database, a meta-
database comprising data from ten resources (DIP, IntAct,
MINT, BioGRID, BIND, CORUM, MPact, HPRD, MPPI,
OPHID [41-51]), and the String v9.0 database [52] which
includes both experimentally validated as well as compu-
tationally predicted interactions. The union of reported
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interactions in these databases was used to establish our
PPI network. We utilized a score filter of 0.75 on the
STRING interactions as a tradeoff between reliability of
included interactions and sufficient network density for
further computations. Different thresholds between 0.6
and 0.9 were tested for the predicted interactions from
STRING. For higher scores, the predicted interactions did
not add much to the existing pool of interactions, and
subsequent clustering resulted in few to no subnetworks.
Conversely, for lower scores, the subnetworks included
broad networks with multiple, non-specific functional
annotations. A score of 0.75 led to optimal subnetworks
that were functionally specific, and returned a reasonable
number of subnetworks for further analysis. The over-
all procedure resulted in a protein interaction network
comprising 15,383 proteins and 337,413 interactions from
STRING and iRefIndex.
RNAi screening data:
We thenmapped data from seven published genome-wide
RNAi screens to the PPI network, including three human
immunodeficiency virus-1 (HIV-1) screens [10,12,53],
three Hepatitis C Virus (HCV) screens [13,18,54] and one
west Nile virus (WNV) screen [11]. Further data analysis
was then performed individually using only screens tar-
geting the same virus (intra-species), as well as across all
seven screens (inter-species).
Submodule identification and statistical testing:
We used the ClusterONE algorithm to detect overlapping
subnetworks in the human PPI network. ClusterONE is
a neighborhood-expansion, greedy graph clustering algo-
rithm [55]. It is able to take edge weights corresponding
to confidence scores into account in the clustering, and
allows overlapping clusters where individual proteins may
be part of more than one cluster. We used default val-
ues for most parameters of the ClusterONE algorithm,
except for the merge-method parameter which was set
to multi to merge highly overlapping clusters, as well
as the minimum cluster size parameter, which we var-
ied between 25 and 100. The variation of the cluster size
parameter leads to clusters of different granularity, from
very small, highly cohesive clusters, to larger and more
heterogeneous clusters. Both may be desirable for the
analysis of virus-targeted subnetworks, we therefore con-
tinued analysis with a redundant set of larger and smaller,
overlapping clusters; we label this set of clustersCall in the
following. Note that these clusters are not merged or inte-
grated further, but rather Call is a set of different clusters.
After clustering, we tested for significant enrichment of
RNAi hits within each cluster in Call using Fisher’s exact
test, with significance level α = 0.05, resulting in the set
Chit ⊂ Call of clusters significantly enriched with RNAi
hits. We note that the clusters in Chitmay still overlap and
may even contain clusters that are subsets/supersets of
one another.
Submodule filtering and cluster selection:
We next used additional filtering criteria to select a small
number of relevant clusters from Chit for further man-
ual analysis. The underlying idea is to choose clusters
that differ significantly from non-significant clusters not
only based on their enrichment with RNAi hits, but also
with respect to their “importance” in the underlying host
PPI network. We selected seven network centrality mea-
sures and two further similarity measures for this filtering
step. We briefly review these measures in the following,
but before repeat some elementary definitions from graph
theory.
Let G = (V ,E) be an undirected graph with nodes
v ∈ V corresponding to proteins and undirected edges
e ∈ E corresponding to interactions between proteins. As
we consider undirected edges only, let ei,j = ej,i. We define
a path P between two nodes s, t ∈ V in a graphG = (V ,E)
as a sequence v0, e0, v1, e1, ..., vk−1, ek−1, vk of nodes vi ∈ V
and edges ei ∈ E, where edge ei connects nodes vi and
vi+1, where vi = vj for all nodes in P, and where v0 := s
and vk := t. The length of P is defined as the number of
edges in the path P.
When clustering the graph G using a graph cluster-
ing algorithm such as ClusterONE, the nodes V in G are
grouped into different clusters. Let VC ⊆ V be one such
cluster. This cluster induces a subnetwork SC = (VC ,EC)
on G, where EC = {ei,j ∈ E : vi, vj ∈ VC}, i.e., the induced
subnetwork consists of the subset VC of nodes, and all
edges in E between these nodes in the original graph G.
Hereafter, we use the term subnetwork to denote the full
subnetwork SC = (VC ,EC), whereas by cluster we refer
only to the subset of nodes VC ⊆ V .
To filter significant clusters VC ∈ Chit further, we used
the following topological properties of the nodes in VC
respectively their induced subnetwork SC :
1. Average node degree: The node degree of a vertex v
in a graph G = (V ,E) is given by
deg(v,G) := |{ev,w ∈ E | ∀w ∈ V }|,
i.e., it is the number of edges in E adjacent to v. The
average node degree of a subnetwork SC = (VC ,EC)
of G is the average degree of all nodes in VC :
CD(SC) = 1|VC |
∑
v∈VC
deg(v, SC),
where |VC | denotes the number of nodes in VC . Note
that we compute the degree with respect to the edge
set EC of the subgraph SC , and not the full graph G.
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2. Average node betweenness: The node betweenness
of a node v ∈ V is the ratio of the number of shortest
paths between any two nodes s, t in G that pass
through v, to the total number of shortest paths
between any two nodes in G. Let (v) be the set of
ordered pairs (s,t ) in V × V , so that s, t and v are
distinct. Then,
CB(v,G) =
∑
(s,t)∈(v,G)
σ (s, t|v,G)
σ (s, t|G) ,
where σ(s, t|G) is the total number of s,t-shortest
paths in G, and σ(s, t|v,G) is the number of shortest
paths from s to t in G that pass through node v. The
average node betweenness CB(SC) of a subgraph SC
is the average node betweenness of all nodes v ∈ VC
in the subgraph SC ,
CB(SC) = 1|VC |
∑
v∈VC
CB(v, SC).
3. Average node closeness: The normalized closeness
of a node v ∈ V is defined as
CClo(v,G) = 1|V | − 1
⎛
⎝ ∑
w∈V ,w =v
d(v,w|G)
⎞
⎠
−1
,
where d(v,w|G) is the length of the shortest path
between two nodes v,w ∈ V . The average node
closeness CClo(SC) of a subgraph SC = (VC ,EC) is
CClo(SC) = 1|VC |
∑
v∈VC
CClo(v, SC).
4. Average eigenvector centrality: Let A = (ai,j) be
the adjacency matrix of G = (V ,E), i.e., A is a
symmetric |V | × |V | matrix with entry ai,j = 1 if
vi,j ∈ E and ai,j = 0 otherwise. The eigenvector
centrality CE of a node v ∈ V is
CE(v,G) = 1
λ
∑
w∈V
aw,vCE(w,G),
where λ is the (absolute) largest eigenvalue of A. The
average eigenvector centrality CE(SC) for a subgraph
SC = (VC ,EC) is defined as
CE(SC) =
∑
v∈VC
1
|VC |CE(v, SC).
Eigenvector centrality is based on the idea that
importance of a node is determined by the
importance of its neighbors: a node becomes more
important the more important its neighbors are.
5. Average clustering coefficient: Let
Nv = {w ∈ V : (v,w) ∈ E} be the set of all neighbors
of a node v ∈ V . The local clustering coefficient of v
is then defined as
CClu(v,G) =
|{ej,k ∈ E : j, k ∈ Nv}|
|Nv|(|Nv| − 1)/2 .
For a given subgraph SC = (VC ,EC), we define the
average clustering coefficient CClu(SC) as the mean
of CClu(v, SC) over all v ∈ VC .
6. Mean path length: The mean path length for a
subgraph SC = (VC ,EC) is the average length of all
shortest paths between all pairs of nodes s, t ∈ VC in
the graph SC :
CP(SC) = 1|VC |(|VC | − 1)
∑
s,t∈VC
d(s, t|SC),
where d(s, t|SC) is the length of the shortest path
between nodes s and t in the subgraph SC .
In addition to the network centrality measures above,
we also used the following similarity coefficients to filter
clusters:
1. Dice similarity coefficient: For any given node
v ∈ V in a graph G, let EGv := {ev,w ∈ E} be the set of
edges adjacent to v. The dice similarity coefficient of
the edge sets EGv and EGw of two nodes v,w ∈ V is
defined as
CDS(v,w,G) = 2|E
G
v
⋂
EGw |
|EGv | + |EGw |
.
The average dice similarity of a subnetwork
SC = (VC ,EC), VC ⊆ V , is
CDS(SC) = 2|VC |(|VC | − 1)
∑
v,w∈VC
CDS(v,w, SC).
2. Wang similarity coefficient: This coefficient is
biologically motivated and is based on similarity
between gene ontology terms. Wang similarity takes
the hierarchical structure of the GO graph into
account by aggregating the information of ancestor
terms when comparing two GO annotations [56].
Writing CG(v,w) for the Wang similarity between
the GO annotations of nodes v and w, we compute
the within-cluster similarity CG(SC) as the average
Wang similarity CG(v,w) between all pairs of genes
v,w in the subnetwork SC .
We note that a number of different measures have been
proposed to compute the semantic similarity between
two GO terms, for a comprehensive review see Pesquita
Amberkar and Kaderali Algorithms for Molecular Biology  (2015) 10:6 Page 6 of 15
et al. [57]. The choice of GO semantic similarity measure
and a comparative evaluation of different measures are
still subject to debate in the literature, as no gold standard
exists, and different studies come to different conclusions
[57]. The choice of similarity measure is therefore some-
what arbitrary and a matter of personal preferences. We
opted for Wang similarity because of own good experi-
ences with this coefficient in previous work, and because
it is implemented in the GOSemSim package in R [58],
which helped seamless integration into our analysis script.
We note however that Wang similarity can easily be
replaced by other semantic similarity measures in our
analysis pipeline.
Filtering of clusters in Chit was performed using the
above topological and similarity measures as follows: We
computed all topological and similarity measures for each
subnetwork in Call, and performed a Wilcoxon test to
assess differences of means of significantly enriched sub-
networks in Chit with randomly selected clusters in Call \
Chit of the same size. Clusters that yielded a significant dif-
ference of the mean for all or all but one topological and
semantic similarity measure at a significance level of 5%
were considered for further analysis. By this, we ensure
a stringent selection of subnetworks for further analysis:
Resulting subnetworks are both enrichted with hits from
the RNAi screens, and show topological properties that
distinguish them from random clusters. In combination,
these criteria resulted in a stringent selection of subnet-
works, compare Table 1. We note that in theory, due to
the variation of the cluster size parameter in ClusterONE,
Chit may contain clusters that are subsets/supersets of
one another, however after filtering using the similarity
and centrality measures we did not observe clusters that
were subsets or supersets of other clusters in the analysis
performed here.
Software and availability:
We implemented our data analysis pipeline in R [59].
Graph based calculations and reconstruction of subnet-
works were performed using the iGraph library [60].
Network visualization was performed using Cytoscape
[61]. All Reactome pathway and GO based enrichments
were computed using the Bioconductor packages clus-
terProfiler and ReactomePA [62,63]. Semantic similarities
were computed using the GOSemSim package [58]. R-
code and data used are available on request from the
authors.
Results
Given the long and often largely non-overlapping hit lists
from RNAi screens targeting viral infection, a central aim
of our analysis was to select a small number of most sig-
nificant, infection-relevant host protein subnetworks for
further manual analysis, and thus to pick most promising
candidates from the original screens for functional char-
acterization. We are therefore interested in a small set of
significant clusters, that are both enriched with hits from
the RNAi screens, and play a central role in the host or
virus-host protein interaction network.
We used RNAi data from seven different, published
genome-wide RNAi screens focusing on the three viruses
HIV [10,12,53], HCV [13,18,54] and WNV [11]. Hit lists
from screens targeting the same virus were combined
and analyzed in a virus-specific way, as well as all data
pooled for pan-viral analysis of host restriction and host
dependency factors. Data were analyze as described in
Table 1 P-values of Wilcoxon test to determine significance of mean values of network centralities and semantic
measures for subnetwork
HIV HCV Combined
Centrality measure s66 s52 s43 s64 s46 s52 s239
Betweenness < 0.0001 0.0131 0.0247 0.0005 0.0131 0.0131 0.0040
Closeness < 0.0001 0.0131 0.0247 0.0005 0.0131 0.0131 0.0040
Clustering Coefficient < 0.0001 0.0247 0.0001 0.0005 0.0131 0.0131 0.0040
Eigenvector Centrality < 0.0001 0.0131 1 1 1 0.0057 0.0057
Node Degree < 0.0001 1 0.0247 0.0005 0.0211 0.0131 0.0040
Path Length < 0.0001 0.0131 0.0247 0.0002 0.0131 0.0131 0.0040
Dice Similarity < 0.0001 0.0131 0.0247 0.0005 0.0131 0.0131 0.0040
Wang Sim. (GO.BP) 0.0004 0.0286 0.5926 0.6009 0.0284 0.0286 0.0136
Wang Sim. (GO.CC) 0.0004 0.0286 0.5926 0.0315 0.0284 0.0286 0.0136
Wang Sim. (GO.MF) 0.0004 0.0286 0.0498 0.7713 1 0.3429 0.1077
AWilcoxon test was used to determine the significance of network centrality measures and semantic similarity measures of subnetworks significantly enriched with
RNAi screening hits. Average similarity measures over all nodes in a given enriched cluster were tested against non-enriched subnetworks of comparable size, using a
Wilcoxon test to assess significance of the differences between the means for each of the given network centrality and semantic similarity measures. Shown are
resulting p-values for two clusters for HIV, two clusters for HCV, and three combined clusters.
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Materials and methods and as illustrated in Figure 1.
Analysis of the single West Nile virus screen did not
yield significant results after filtering, probably due to
too small number of hits included in the analysis. We
did include this virus in the pan-viral analysis. Table 2
gives an overview over resulting hits for HIV-1 and HCV,
discussed in more detail below.
Human immunodeficiency virus-1 (HIV-1)
Two significant subnetworks of size 52 (HIV_s52) and
66 proteins (HIV_s66), respectively, were obtained from
analysis of the three HIV screens after filtering as
described in Materials and methods. These subnetworks
are shown in Additional file 1: Figure S1 and Additional
file 2: Figure S2, respectively. A Reactome pathway enrich-
ment analysis of the subnetworks as well as the original
screens is shown in Figure 2A. The pathway analysis of
the three screens individually yields the expected, albeit
very general pathways, such as Immune System,HIV Infec-
tion, Metabolism or Signal Transduction. This is a typical
outcome for geneset or pathway enrichment analysis with
large hit lists from RNAi screens, which often results in
very unspecific and general terms as the only significant
outcomes. In contrast, due to the inclusion of protein
neighborhoods and focusing on enriched subnetworks of
the host protein network, much more specific results can
be obtained using our approach, as illustrated for the
HIV_s52 and HIV_s66 subnetworks (Figure 2A).
The HIV_s52 subnetwork consists primarily of genes
involved in transcription, and comprises in particular
subunits of the mediator complex. This complex is a
transcriptional coactivator, involved in the regulation of
expression of RNA polymerase II transcripts, and thus
of all protein coding and most non-coding RNA genes
[64]. The mediator complex has previously been identi-
fied in the context of HIV-1 infection in the meta-analysis
by Bushman et al. [24] and was a major hit in the RNAi
screens by Zhou et al. [53] and König et al. [12]. This
discovery has led to different hypotheses about the role
of the mediator complex in HIV infection. While Zhou
et al. suggest that mediator complex subunits are required
for Tat-activated transcription, König et al. speculate that
the complex may be involved in reverse transcription. The
exact role of the mediator complex in the HIV lifecycle
still needs to be determined. Interestingly, transcriptional
regulation does not show up in individual enrichment
Table 2 Key results achieved for HIV-1 and HCV
Virus Subnetwork Predicted novel host factors
HIV HIV_s52
• KDM4B - lysine-specific demethylase 4B
HIV_s66
• HNRNPK - Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP)
• HNRNPL - Heterogeneous nuclear ribonucleoprotein L
• HNRNPM - Heterogeneous nuclear ribonucleoprotein M
• HNRNPU - Heterogeneous nuclear ribonucleoproteinU (hnRNP U) (Scaffold attachment factor A) (SAF-A) (p120) (pp120)
• RBM11 - Splicing regulator RBM11 (RNA-binding motif protein 11)
• RBM41 - RNA-binding protein 41 (RNA-binding motif protein 41)
• RBM42 - RNA-binding protein 42 (RNA-binding motif protein 42)
• RBM4B - RNA-binding protein 4B (RNA-binding motif protein 30) (RNA-binding motif protein 4B) (RNA-binding protein 30)
• ‘RBM7 - RNA-binding protein 7 (RNA-binding motif protein 7)
• SRSF3 - Serine/arginine-rich splicing factor 3 (PremRNA-splicing factor SRP20) (Splicing factor, arginine/serine-rich 3),
• SRSF4 - Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor,
arginine/serine-rich 4)
• SRSF10 - Serine/arginine-rich splicing factor 10 (40 kDa SR-repressor protein)
HCV HCV_s43
• αβ Crystallin Complex subunits (CRYBAA, CRYBAB, CRYBA1, CRYBA2, CRYBA4, CRYBA1, CRYBB1, CRYBB2, CRYBB3)
• Heat-shock proteins (HspB1, HspB2, HspB6, HspB7 and HspB8)
HCV_s64
• Tyrosine-protein phosphatase non-receptors, various types (PTP-1B, TCPTP, PTP-H1, PTPase MEG2)
• Tankyrase-1 (Poly-ADP-ribosyltransferase)
The table shows the main novel findings for HIV-1 and hepatitis C virus obtained by mapping RNAi data to protein interaction networks, and using the clustering and
filtering procedure proposed here. Results for the combined analysis are given in Additional file 5.
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Figure 2 HIV and HCV enrichment analysis. The figure shows Reactome pathways annotations significantly enriched with hits from the individual
RNAi screens or significant clusters from (A) HIV and (B) HCV. Size of the dots indicates percentage of genes in the respective annotation category
that were significant in the screen, color codes statistical significance of enrichment.
analysis of the screens by König et al. and Zhou et al.
In contrast, it is highly significant for the HIV_s52 sub-
network, underlining the gain in power brought by a
meta-analysis and by inclusion of protein neighborhoods
in analyzing RNAi data (Figure 2).
The HIV_s66 subnetwork comprises many members
of the heterogeneous nuclear ribonucleoprotein subunits
(hnRNP) and serine/arginine rich splicing factors. The dif-
ferent hnRNP subunits participate in different steps in
the RNA metabolism, including splicing, export, local-
ization and translation [65]. Similarly, several of the
serine/arginine rich splicing factors in the HIV_s66 sub-
network are known to have direct interactions with HIV
viral proteins [66]. Correspondingly, enriched pathways in
the HIV_s66 subnetwork are related to mRNA process-
ing and splicing (Figure 2A). A recent study by Lund et al.
focused on the hnRNP complexes, andmechanistic details
of its involvement in HIV-1 infection [67]. The authors
report that loss of the hnRNP A1 subunit increases the
expression of HIV Gag and Env, but with no subsequent
increase of viral RNA. In contrast, depletion of hnRNP
A2 increases both Gag protein and HIV-1 RNA levels.
Changes in expression of different isoforms of hnRNP D
had very diverse effects, where some isoforms increased
HIV-1 gene expression, whereas others brought the cells
into a non-permissive state.
Hepatitis C virus
We next repeated the analysis for the three hepatitis
C virus screens by Li et al., Tai et al. and Lupberger
et al. [13,18,54]. Combined analysis and submodule filter-
ing as above resulted in two different subnetworks with 43
proteins (HCV_s43) and 64 proteins (HCV_s64), respec-
tively, compare Additional file 3: Figure S3 and Additional
file 4: Figure S4. Reactome enrichment showed that both
modules were functionally very specific (Figure 2B).
The HCV_s43 module mainly contains dual specificity
protein phosphatases, heat shock proteins (HSPs), crys-
talline proteins and mitogen-activated protein kinases
(MAPKs). In particular the MAPKs are interesting, as
they play a key role in cell growth and proliferation and
are associated with hepatocellular carcinoma - the end
stage of chronic HCV infection [68]. On the other hand,
the HSPs and crystalline proteins both act as chaperones.
Hsp72, one of the heat shock proteins in the HCV_s43
network, is known to be a positive regulator of HCV RNA
replication by increasing replication complex levels [69];
furthermore, Lim et al. recently showed that the viral
protein NS5A increases Hsp72 levels through the tran-
scription factors HSF1 and NFAT5 [70], thus increasing
its own replication. Reactome enrichment analysis of the
HCV_s64 subnetwork shows enrichment in cytokine sig-
naling, growth hormone receptor signaling, and ERBB4
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signaling. The subnetwork in particular comprises sev-
eral interleukin receptors and subunits, as well as insulin
receptor and receptor substrate. The interleukins play an
important role in suppression of infection, it is thus no
surprise that HCV itself interacts with different inter-
leukins to inhibit the cellular antiviral response [71-73].
Pan-viral host factors
To get an overview over pan-viral host factors, we next
pooled all seven screens (3 HIV, 3 HCV, 1 WNV) and
analyzed the combined hit list [10-13,18,53,54]. Using
our pipeline, we identified three highly significant sub-
networks of size 46 proteins (Combi_s46), 52 proteins
(Combi_s52) and a large network with 239 proteins
(Combi_s239). The Combi_s52 network was identical to
the one described for HIV, and is thus not discussed
further here (see results on HIV).
The Combi_s239 subnetwork contains 17 tyrosine-
protein kinases, 6 tyrosine-protein phosphatase non-
receptors, 5 insulin receptor substrates, and an insulin
receptor (see Additional file 5 and Figure 3). Indeed,
insulin resistance is one of the effects observed in HCV
infected patients as the disease progresses. A recent study
identified components of the insulin signaling pathway
that are altered by HCV, conferring insulin resistance in
the patient [74]. The study showed that PTPB1, a tyro-
sine phosphatase, is significantly induced in infected cells.
Supporting evidence also comes from a study by Garcia-
Ruiz et al. who showed that insulin resistance is also
associated with IFN-α resistance in Hep-G2 cells with
increase PTPB activity [75]. Both these resistance types
were lowered using Metformin, in both studies. The pres-
ence of several PTPBs in this network provides a basis for
further experimentation with appropriate drugs that can
keep the insulin-IFN-α resistances in check.
The Combi_s239 subnetwork furthermore contains sev-
eral proteins from the Src kinase family. In WNV, it is
known that e.g. c-Yes, a member of this family, is required
for transportation of virions through the secretory path-
way [76]. Several of the Src kinase family members are
activated by HIV Nef [77], and also HCV NS5A induces
phosphorylation events in the Src family [78-80].
The Combi_s46 subnetwork consists primarily of
SMAD and zinc finger proteins. The SMADs are involved
in TGF-β signaling, where they activate downstream
gene expression [81,82]. TGF-β is an immunosuppres-
sive cytokine, its modulation is therefore advantageous
for parasitic viruses [83,84]. Indeed, HCV suppresses the
TGF-β mediated transcriptional activation by the full-
length polyprotein and NS3-viral proteins in a SMAD-
R dependent manner [85]. Zinc finger proteins on the
other hand have antiviral activity: Sakkhachornphop et al.
have shown that a zinc-finger protein targets the 2-long
terminal repeat (2-TLR) circle junctions of HIV-1 DNA
[86,87]. This region of the HIV genome is cleaved by
HIV integrase, and blocking this site restricts HIV-1 gene
transcription.
Mapping tissue-specific expression data
Given the filtered, significant subnetworks for the dif-
ferent viruses, we next addressed the problem to select
suitable candidates for further experimental validation
from the subnetworks, and thus ultimately possible tar-
gets for antiviral drugs. Of particular interest are proteins
that are strongly expressed in tissues targeted by a given
virus. Such tissue-specific or cell-line specific expression
data is widely available through the Human Protein Atlas
[88].We overlaid subnetworks with tissue-specific expres-
sion data, and retained only proteins in the subnetwork
that had moderate or high expression levels in the Pro-
tein Atlas database. Given the high rates of false negatives
in RNAi screens [27], we do not necessarily require that
candidate genes are direct hits in any of the screens.
For hepatitis C virus, expression levels were selected
from hepatocytes, resulting in three proteins that
remained in the HCV-s64 subnetwork: Tankyrase-1
(TNKS1, also known as PARP5A, PARPL, TIN1 and
TINF1), Sarcoplasmic/endoplasmic reticulum calcium
ATPase 1 (SERCA1) and JAK2, compare Figure 4. Of
these, TNKS1 and SERCA1 have not been reported as
hits in any of the three HCV screens used. Interestingly,
SERCA2, a close family member of SERCA1, has been
shown to play an important role in HCV core induced ER
stress and control of apoptosis [89]. As SERCA1 is closely
interacting with SERCA2 and has similar functions, a sim-
ilar role might be played by SERCA1 in HCV infection.
TNKS1 on the other hand is involved in WNT signal-
ing, regulation of telomere length, and vesicle trafficking.
TNKS1 has previously been suggested as an attractive
anti-cancer target [90], and is involved in HCV-induced
apoptosis [91]. In case of HIV, we filtered proteins based
on expression in macrophages. This resulted mainly in
different subunits of the heterogeneous nuclear ribonucle-
oproteins (hnRNPs) as highly expressed putative antiviral
targets.
Discussion and conclusion
Genome wide RNAi screening experiments typically
result in lists of hundreds of “hit” genes, and the selec-
tion of promising candidates for biochemical follow-up
as well as their placement in the underlying molecular
processes is a significant challenge [20]. To complicate
matters further, in particular for viral RNAi screens, very
low overlap has been reported even for screens targeting
the same virus [24]. High false negative rates are likely
a major contributing factor to this problem [27]. While
geneset enrichment approaches can help to interpret lists
of hit genes, they in our experience typically lead to very
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Figure 3 Combi_s239 subnetwork- subnetwork resulting from analysis of all seven RNAi screens for three different viruses (HIV, HCV,
WNV). Nodes represents proteins and node labels represent Uniprot identifiers. All colored nodes represent hits from a RNAi screen, white nodes
represent proteins from the Dharmacon library and black nodes are proteins from the Hu.PPI but not in the Dharmacon library.
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Figure 4 The figure shows the HCV_s64 subnetwork, including TNKS1, SERCA1 and JAK2. Tissue-specific expression data from the Human
Protein Atlas were overlaid on the network using data from hepatocytes.
general, unspecific terms and often fail to achieve statisti-
cal significance for concrete, specific biological processes
or pathways when applied to RNAi screening data. This
problem clearly is aggravated if hit lists are prone to high
levels of false negative results, and it is then a very chal-
lenging problem to pick interesting candidates for further
experimental characterization.
In this work, we have developed a network-based
approach for gene prioritization. The simple underlying
idea is to interpret hit genes from RNAi screening exper-
iments in their biological context, by taking the host cell
protein-protein interaction (PPI) network into account.
We cluster this PPI network to identify highly connected
subnetworks, and then map the RNAi data onto this clus-
tered network to find enriched submodules. Additional
experimental data such as known virus-host interactions,
gene expression data or e.g. proteomics data can eas-
ily be integrated at this stage and can be included in
the network-based analysis. Similarly, it is straightfor-
ward to combine data from different screens for the same
or even for different viruses at this level, to enable a
network-based meta analysis of virus-host interactions.
We exemplify this in a meta-analysis over seven differ-
ent viral RNAi screens targeting three different viruses.
In contrast to traditional geneset enrichment analysis, no
prior definition of relevant gene sets (e.g. gene ontol-
ogy annotations or biological pathways) is required, but
instead gene sets are automatically defined by clustering
of the PPI network. This is indeed an advantage and dis-
advantage at the same time: While we do not require
a-priori defined gene sets for our analysis, our approach
clearly depends on the underlying PPI network that must
be given as input. Unfortunately, in particular for yeast-2-
hybrid experiments, such networks are known to contain
many false positive connections, which may negatively
impact our analysis. Furthermore, we specifically opted
to include high-confidence predicted interactions from
the STRING database, which was required to obtain a
sufficiently dense, connected network to permit further
analysis. There is thus an inherent tradeoff between reli-
ability of the underlying network used and sufficient net-
work size and connectivity to allow a meaningful analysis.
Similarly, the choice of clustering algorithm and similar-
ity measures used to further filter significant networks
will impact results. As proteins often perform multiple
functions in a cell, we decided to use a clustering algo-
rithm that allows for overlaps between different clusters,
permitting individual proteins to be part of several differ-
ent subnetworks. We furthermore performed our analysis
with a whole range of parameters for the desired cluster
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size, using a redundant set of clusters of different sizes in
the ensuing network centrality and similarity based filter-
ing step. We thereby let the algorithm automatically select
significant clusters of all sizes.
As no gold standard is available for virus-host interac-
tion networks and RNAi screening data analysis, it is very
difficult to assess the influence these different cluster-
ing parameters and false-positive or false-negative inter-
actions in the underlying PPI network have on results.
Reassuringly, our results show that we recover many of
the known hits for the different viruses used in this
study, and top candidates resulting from our gene prior-
itization approach are largely confirmed by other meta
analysis approaches that have been performed using dif-
ferent methods. For example, Bushman et al. performed
a meta-analysis of all published HIV-1 RNAi screens in
2009 [24], and also identified the mediator complex and
hnRNPs as major HIV-1 host cell factors in their analysis.
The mediator complex is also reported by Murali et al. in
their analysis [38], whereas two further studies by Bader
and Nepusz, respectively, identified the hnRNPs using
MCODE, a different clustering algorithm than employed
in our work [55,92]. Other related approaches include the
work by MacPherson et al. [39], Dickerson et al. [30],
Snijder et al. [37] and the VirHostNet database developed
by Navratil et al. [93]. A unique aspect of our analysis
is the comparative analysis over different viruses, with a
specific focus on functional subnetworks in this pan-viral
meta-analysis.
There are two further assumptions that we make in
our analysis, that are worthy a brief discussion. The first,
noncritical assumption we made in this manuscript con-
cerns the expression analysis, overlaying the tissue specific
expression data for hit selection onto the PPI network.We
here made the assumption that low tissue expression of a
gene implies that the gene is not a good target and was
used as reason to exclude the gene from further consider-
ation. We use this assumption here to filter genes within
a subnetwork, but this is clearly a very crude approxima-
tion and many cases are conceivable where also a lowly
expressed gene may be a very good drug target and may
play an important role in infection. Obviously the inverse
is not true: High expression alone does not make a gene a
good target. The second assumption is critical: Our sub-
network analysis is based on the assumption that due to
technical and biological variability, different genes within
a subnetwork may be identified in different screens, but
that indeed the entire subnetwork or sub-complex is a
relevant host factor. In particular in light of high false neg-
ative rates in RNAi screens [27] and further variability
due to e.g. different experimental protocols, cell lines and
viral genotypes used and different transfection and infec-
tion times, it is very plausible that different genes in the
same pathway or subnetwork will be identified in different
screens, even when targeting the same virus. Our further
subnetwork analysis therefore requires that subnetworks
resulting from the clustering have high functional consis-
tency, in the sense that the proteins within one cluster
need to be involved in the same biological process or
pathway, whereas different clusters should be functionally
distinct – this is a conditio sine qua non when speaking of
significance of a subnetwork. In line with this, the iden-
tification of putative targets in our analysis focuses on all
proteins in a subnetwork, even if they did not show up
as hits in any of the original screens considered. Before
proceeding with such hits in a drug development pipeline,
clearly additional experiments are required to confirm a
role of these hits in the infection process, and in particular
an effect of targeting the candidate gene on viral infec-
tion. As cells have many redundant mechanisms, even if a
host gene is involved in viral infection, targeting this gene
may not be sufficient to inhibit viral replication. Detailed
mathematical modeling of the underlying processes in the
subnetwork may then be a good option to identify opti-
mal treatment strategies, but goes beyond the scope of the
present work [94].
While we have developed the approach presented in
this manuscript for the analysis of viral RNAi screen-
ing data, the general pipeline is applicable to any type
of experiment resulting in long “hit” gene lists. Exam-
ples include gene expression data e.g. from microarray or
transcriptome sequencing experiments, methylation pro-
files, genomic data such as array CGH or DNA sequenc-
ing, and proteomic assays based on mass spectrometry
or protein arrays. Similarly, biological questions address-
able with our pipeline extend well beyond viral infection,
and basically include any assay where a mechanistic bio-
logical understanding is sought for based on large-scale,
high-throughput data sets. In particular with the current
developments in and increasing availability of big data in
biology, network-based analysis approaches are a funda-
mental tool to interpret and understand the underlying
biological processes, and will become more and more
important as available data grows. We demonstrate the
use of such network-based analysis methods on the con-
crete example of virus-host interactions in the present
work.
Additional files
Additional file 1: Figure S1. HIV_s52 subnetwork: The figure shows the
HIV_s52 subnetwork resulting from the analysis of the HIV screens. The
subnetwork primarily consists of genes involved in transcription, and
particularly comprises the mediator complex.
Additional file 2: Figure S2. HIV_s66 subnetwork: Shown is the HIV_s66
subnetwork resulting from the HIV screen analysis. The network essentially
contains splicing factors and members of the hnRNP complex.
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Additional file 3: Figure S3. HCV_s43 subnetwork: This subnetwork from
the analysis of the three HCV screens comprises mainly heat shock proteins
and proteins of the MAPK pathway.
Additional file 4: Figure S4. HCV_s64 subnetwork: The HCV_s64
subnetwork is one of two significant subnetworks for the HCV screens, and
contains interleukin receptors, cytokines and growth hormone receptors.
Additional file 5: List of proteins in Combined_s239 subnetwork. This
xls file contains the proteins involved in the Combined_s239 network,
together with additional annotation.
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